In 2013, a joint ACR–EULAR committee developed new classification criteria for SSc, incorporating made advances, including specific antibodies such as anti-topoisomerase I (ATA), anti-centromere (ACA), and anti-RNA polymerase III (RNAP3). This evidence concerns the gene ATM and systemic sclerosis.